These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Remission of established disease in diabetic NOD mice induced by anti-CD3 monoclonal antibody]. Chatenoud L; Thervet E; Primo J; Bach JF C R Acad Sci III; 1992; 315(6):225-8. PubMed ID: 1468025 [TBL] [Abstract][Full Text] [Related]
6. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice. De Aizpurua HJ; French MB; Chosich N; Harrison LC J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856 [TBL] [Abstract][Full Text] [Related]
7. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice]. Liu F; Yu M; Zhu Q Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396 [TBL] [Abstract][Full Text] [Related]
8. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells. Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255 [TBL] [Abstract][Full Text] [Related]
9. Anti-CD3 mAbs for treatment of type 1 diabetes. Kaufman A; Herold KC Diabetes Metab Res Rev; 2009 May; 25(4):302-6. PubMed ID: 19319985 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms mediating anti-CD3 antibody efficacy: insights from a mathematical model of type 1 diabetes. Young DL; Ramanujan S; Kreuwel HT; Whiting CC; Gadkar KG; Shoda LK Ann N Y Acad Sci; 2006 Oct; 1079():369-73. PubMed ID: 17130581 [TBL] [Abstract][Full Text] [Related]
11. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells. Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395 [TBL] [Abstract][Full Text] [Related]
12. Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse. Hawa MI; Valorani MG; Buckley LR; Beales PE; Afeltra A; Cacciapaglia F; Leslie RD; Pozzilli P Horm Metab Res; 2004 Sep; 36(9):620-4. PubMed ID: 15486813 [TBL] [Abstract][Full Text] [Related]
13. [The effects of NKG2D mAb on the survival of allogeneic transplanted islets in spontaneous diabetic nonobese diabetic mice]. Pan H; Lu YR; Zhang ZD; Jin X; Wei LL; Yuan Y; Lu HM; Mai G Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):836-9, 848. PubMed ID: 21302453 [TBL] [Abstract][Full Text] [Related]
14. Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4. Hayward AR; Shriber M; Cooke A; Waldmann H J Autoimmun; 1993 Jun; 6(3):301-10. PubMed ID: 8104407 [TBL] [Abstract][Full Text] [Related]
15. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815 [TBL] [Abstract][Full Text] [Related]
16. Effects of anti-CD3 monoclonal antibody in salivary glands of spontaneously diabetic mice. Metidieri HT; Mancio RD; Mayoral ÉE; Rojas FA; Peroni LA; Ferri AT; Lourenço EA; Caldeira EJ Microsc Res Tech; 2012 Jul; 75(7):928-34. PubMed ID: 22298388 [TBL] [Abstract][Full Text] [Related]
17. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM. Wilson SS; DeLuca D J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074 [TBL] [Abstract][Full Text] [Related]
18. Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes. Funda DP; Kaas A; Tlaskalová-Hogenová H; Buschard K Diabetes Metab Res Rev; 2008; 24(1):59-63. PubMed ID: 17607660 [TBL] [Abstract][Full Text] [Related]
19. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells. Sherry NA; Chen W; Kushner JA; Glandt M; Tang Q; Tsai S; Santamaria P; Bluestone JA; Brillantes AM; Herold KC Endocrinology; 2007 Nov; 148(11):5136-44. PubMed ID: 17673522 [TBL] [Abstract][Full Text] [Related]
20. Attempt to prevent the development of diabetes in non-obese diabetic mice by oral vanadate administration. Meyerovitch J; Waner T; Sack J; Kopolovic J; Shemer J Isr Med Assoc J; 2000 Mar; 2(3):211-4. PubMed ID: 10774269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]